Location: New York, NY
CIK: 0001746382 · Show all filings
Period: Q4 2022 (← Previous) (Next →)
Filing Date: Feb 14, 2023
Total Value: $197M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | ASTRIA THERAPEUTICS INC | 1,355,372 | $20.18M | 10.3% | $12.97 | — | COM | 04635X102 |
| ADMA | ADMA BIOLOGICS INC | 2,870,000 | $11.14M | 5.7% | $1.43 | +115.9% | COM | 000899104 |
| — | CHINOOK THERAPEUTICS INC | 385,000 | $10.09M | 5.1% | $15.26 | — | COM | 16961L106 |
| — | BELLUS HEALTH INC NEW | 1,132,000 | $9.305M | 4.7% | $4.52 | — | COM NEW | 07987C204 |
| — | PEPPERLIME HEALTH ACQUSTN CO | 735,000 | $7.504M | 3.8% | $9.87 | — | CLASS A ORD SHS | G70021103 |
| — | AKERO THERAPEUTICS INC | 125,000 | $6.85M | 3.5% | $34.05 | — | COM | 00973Y108 |
| — | CYMABAY THERAPEUTICS INC | 1,025,000 | $6.427M | 3.3% | $3.38 | — | COM | 23257D103 |
| — | VERONA PHARMA PLC | 215,000 | $5.618M | 2.9% | $10.22 | — | SPONSORED ADS | 925050106 |
| — | INTRA-CELLULAR THERAPIES INC | 100,000 | $5.292M | 2.7% | $55.37 | — | COM | 46116X101 |
| AMLX | AMYLYX PHARMACEUTICALS INC | 140,000 | $5.173M | 2.6% | $32.85 | +8.0% | COM | 03237H101 |
| RYTM | RHYTHM PHARMACEUTICALS INC | 170,000 | $4.95M | 2.5% | $18.60 | +38.2% | COM | 76243J105 |
| ACLX | ARCELLX INC | 150,000 | $4.647M | 2.4% | $20.02 | +14.6% | COMMON STOCK | 03940C100 |
| REPL | REPLIMUNE GROUP INC | 160,000 | $4.352M | 2.2% | $20.78 | 0.0% | COM | 76029N106 |
| — | KARUNA THERAPEUTICS INC | 22,000 | $4.323M | 2.2% | $160.49 | — | COM | 48576A100 |
| XTNT | XTANT MED HLDGS INC | 6,246,291 | $4.123M | 2.1% | $1.78 | -63.2% | COM NEW | 98420P308 |
| — | IVERIC BIO INC | 190,000 | $4.068M | 2.1% | $11.87 | — | COM | 46583P102 |
| TNDM | TANDEM DIABETES CARE INC | 90,000 | $4.045M | 2.1% | $45.27 | 0.0% | COM NEW | 875372203 |
| GKOS | GLAUKOS CORP | 91,000 | $3.975M | 2.0% | $47.15 | +4.6% | COM | 377322102 |
| ESPR | ESPERION THERAPEUTICS INC NE | 620,000 | $3.863M | 2.0% | $8.01 | -10.7% | COM | 29664W105 |
| — | OUTLOOK THERAPEUTICS INC | 3,327,404 | $3.594M | 1.8% | $1.08 | — | COM NEW | 69012T206 |
| RMD | RESMED INC | 17,000 | $3.538M | 1.8% | $220.69 | -3.3% | COM | 761152107 |
| — | AKOYA BIOSCIENCES INC | 330,000 | $3.158M | 1.6% | $12.51 | — | COM | 00974H104 |
| QTRX | QUANTERIX CORP | 224,800 | $3.113M | 1.6% | $12.02 | -4.2% | COM | 74766Q101 |
| MYGN | MYRIAD GENETICS INC | 212,000 | $3.076M | 1.6% | $19.38 | -3.9% | COM | 62855J104 |
| KRMD | KORU MEDICAL SYSTEMS INC | 855,000 | $3.052M | 1.6% | $3.75 | -26.5% | COM | 759910102 |
| — | NEVRO CORP | 76,000 | $3.01M | 1.5% | $86.27 | — | COM | 64157F103 |
| PACB | PACIFIC BIOSCIENCES CALIF IN | 365,000 | $2.986M | 1.5% | $8.62 | 0.0% | COM | 69404D108 |
| BHVN | BIOHAVEN LTD | 200,000 | $2.776M | 1.4% | $14.12 | 0.0% | COM | G1110E107 |
| — | CTI BIOPHARMA CORP | 450,000 | $2.704M | 1.4% | $5.83 | — | COM | 12648L601 |
| SIBN | SI-BONE INC | 195,000 | $2.652M | 1.3% | $15.79 | -7.7% | COM | 825704109 |
| NEO | NEOGENOMICS INC | 285,000 | $2.633M | 1.3% | $9.32 | 0.0% | COM NEW | 64049M209 |
| — | CARA THERAPEUTICS INC | 195,960 | $2.105M | 1.1% | $10.54 | — | COM | 140755109 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 17,500 | $2.09M | 1.1% | $92.29 | +26.9% | COM | 64125C109 |
| COLL | COLLEGIUM PHARMACEUTICAL INC | 90,000 | $2.088M | 1.1% | $16.82 | +19.9% | COM | 19459J104 |
| PCVX | VAXCYTE INC | 43,000 | $2.062M | 1.0% | $39.24 | 0.0% | COM | 92243G108 |
| — | TG VENTURE ACQUISITION CORP | 200,000 | $2.038M | 1.0% | $10.25 | — | UNIT 08/15/2028 | 87251T208 |
| PLRX | PLIANT THERAPEUTICS INC | 100,000 | $1.933M | 1.0% | $19.13 | +9.3% | COM | 729139105 |
| — | SAGE THERAPEUTICS INC | 50,000 | $1.907M | 1.0% | $38.14 | — | COM | 78667J108 |
| — | BIOLINERX LTD | 3,103,635 | $1.831M | 0.9% | $0.92 | — | SPONSORED ADS | 09071M205 |
| — | AULT DISRUPTIVE TECHS CORP | 150,000 | $1.538M | 0.8% | $9.97 | — | COM | 05150A104 |
| — | TG THERAPEUTICS INC | 100,000 | $1.183M | 0.6% | — | — | Call | 88322Q908 |
| SYRS | SYROS PHARMACEUTICALS INC | 315,070 | $1.131M | 0.6% | $4.34 | 0.0% | COM NEW | 87184Q206 |
| — | WESTERN ACQSTN VENTURES CORP | 100,000 | $1.1M | 0.6% | $10.00 | — | UNIT 09/01/2026 | 95758L206 |
| — | MURPHY CANYON ACQUISITION CO | 100,000 | $1.018M | 0.5% | $10.10 | — | UNIT 01/25/2027 | 626642201 |
| — | ARYA SCIENCES ACQU CORP IV | 100,000 | $1.01M | 0.5% | $9.92 | — | CL A | G31659108 |
| — | COLISEUM ACQUISITION CORP | 85,000 | $853K | 0.4% | $9.95 | — | CLASS A ORD SHS | G2263T123 |
| TSHA | TAYSHA GENE THERAPIES INC | 359,051 | $811K | 0.4% | $2.02 | 0.0% | COM SHS | 877619106 |
| — | SOMALOGIC INC | 310,000 | $778K | 0.4% | $2.51 | — | CLASS A COM | 83444K105 |
| HYREQ | HYRECAR INC | 1,688,120 | $716K | 0.4% | $0.63 | 0.0% | COM | 44916T107 |
| TERN | TERNS PHARMACEUTICALS INC | 70,000 | $713K | 0.4% | $6.66 | 0.0% | COM | 880881107 |
| — | FAT BRANDS INC | 227,000 | $683K | 0.3% | $2.70 | — | *W EXP 07/16/202 | 30258N121 |
| RXST | RXSIGHT INC | 50,586 | $641K | 0.3% | $12.16 | 0.0% | COM | 78349D107 |
| — | POLISHED COM INC | 1,000,821 | $578K | 0.3% | $0.58 | — | COM | 28252C109 |
| PEPG | PEPGEN INC | 40,000 | $535K | 0.3% | $11.15 | +15.8% | COM | 713317105 |
| — | GSR II METEORA ACQUISITN COR | 50,000 | $529K | 0.3% | $10.12 | — | UNIT 02/24/2027 | 36263W204 |
| DDI | DOUBLEDOWN INTERACTIVE CO LT | 60,876 | $514K | 0.3% | $17.61 | — | ADS | 25862B109 |
| — | OPY ACQUISITION CORP I | 50,000 | $501K | 0.3% | $9.80 | — | COM CL A | 671005106 |
| — | COLOMBIER ACQUISITION CORP | 50,000 | $497K | 0.3% | $9.68 | — | CL A | 19533H108 |
| POLWQ | POLISHED COM INC | 6,103,824 | $488K | 0.2% | $2.14 | — | *W EXP 06/02/202 | 28252C117 |
| MDWD | MEDIWOUND LTD | 27,286 | $368K | 0.2% | $10.12 | 0.0% | SHS NEW | M68830112 |
| KURA | KURA ONCOLOGY INC | 28,198 | $350K | 0.2% | $14.54 | 0.0% | COM | 50127T109 |
| ABEO | ABEONA THERAPEUTICS INC | 108,696 | $335K | 0.2% | $3.74 | 0.0% | COM NEW | 00289Y206 |
| — | TROIKA MEDIA GROUP INC | 2,672,640 | $310K | 0.2% | $0.12 | — | COM | 89689F305 |
| — | LIGHTNING EMOTORS INC | 581,852 | $213K | 0.1% | $0.37 | — | COM | 53228T101 |
| — | WEARABLE DEVICES LTD | 1,411,600 | $171K | 0.1% | $0.21 | — | *W EXP 09/14/202 | M97838110 |
| — | DIRECT DIGITAL HOLDINGS INC | 180,000 | $140K | 0.1% | $0.73 | — | *W EXP 02/15/202 | 25461T113 |
| — | ASTRIA THERAPEUTICS INC | 7,700 | $115K | 0.1% | — | — | Call | 04635X902 |
| — | HEALTH SCIENCES ACQ CORP 2 | 10,000 | $99,800 | 0.1% | $12.80 | — | ORD SHS | G4411D109 |
| JFBRW | JEFFS BRANDS LTD | 480,770 | $79,327 | 0.0% | $0.17 | — | *W EXP 08/26/202 | M61472110 |
| CINGW | CINGULATE INC | 270,000 | $64,827 | 0.0% | $0.71 | — | *W EXP 12/10/202 | 17248W113 |
| ONFOW | ONFOLIO HOLDINGS INC | 200,000 | $48,000 | 0.0% | $0.15 | — | *W EXP 01/02/202 | 68277K124 |
| — | HARBOR CUSTOM DEVELOPMENT IN | 650,000 | $38,935 | 0.0% | $0.77 | — | *W EXP 10/07/202 | 41150T124 |
| — | NOCTURNE ACQUISITION CORP | 500,000 | $38,900 | 0.0% | $0.38 | — | RIGHT 12/26/2025 | G6580S106 |
| — | NLS PHARMACEUTICS LTD | 200,000 | $38,010 | 0.0% | $0.73 | — | *W EXP 02/02/202 | H57830111 |
| NXGLW | NEXGEL INC | 225,000 | $33,750 | 0.0% | $0.81 | — | *W EXP 12/01/202 | 65344E115 |
| — | LIGHTNING EMOTORS INC | 652,173 | $25,304 | 0.0% | $0.41 | — | *W EXP 05/18/202 | 53228T119 |
| — | PEPPERLIME HEALTH ACQUSTN CO | 367,500 | $24,071 | 0.0% | $0.45 | — | *W EXP 10/01/202 | G70021111 |
| BNCWW | CEA INDUSTRIES INC | 250,000 | $22,500 | 0.0% | $0.68 | — | *W EXP 02/11/202 | 86887P119 |
| — | CHAVANT CAPITAL ACQUISITN CO | 150,000 | $21,705 | 0.0% | $0.48 | — | *W EXP 99/99/999 | G2058L111 |
| — | NEXALIN TECHNOLOGY INC | 105,000 | $21,000 | 0.0% | $0.18 | — | *W EXP 09/15/202 | 65345B110 |
| — | TILRAY BRANDS INC | 7,600 | $20,444 | 0.0% | — | — | Call | 88688T900 |
| BRSWF | BRUUSH ORAL CARE INC | 360,579 | $19,543 | 0.0% | $0.18 | — | *W EXP 08/03/202 | 11750K120 |
| LUCYW | INNOVATIVE EYEWEAR INC | 150,000 | $18,345 | 0.0% | $0.40 | — | *W EXP 08/16/202 | 45791D117 |
| — | HARBOR CUSTOM DEVELOPMENT IN | 600,000 | $17,400 | 0.0% | $0.63 | — | *W EXP 05/09/202 | 41150T116 |
| — | DIGITAL HEALTH ACQUISITION C | 150,000 | $14,835 | 0.0% | $0.10 | — | *W EXP 11/02/202 | 253893119 |
| — | PROSOMNUS INC | 150,000 | $11,790 | 0.0% | $0.08 | — | *W EXP 04/20/202 | 50535E116 |
| SLNWF | SELINA HOSPITALITY PLC | 101,439 | $8,115 | 0.0% | $0.08 | — | *W EXP 10/27/202 | G8059B119 |
| — | EUCRATES BIOMEDICAL ACQU COR | 133,333 | $7,413 | 0.0% | $1.04 | — | *W EXP 10/23/202 | G3141W122 |
| SRZNW | SURROZEN INC | 82,233 | $7,023 | 0.0% | $1.14 | — | *W EXP 08/01/203 | 86889P117 |
| — | OPY ACQUISITION CORP I | 50,000 | $3,225 | 0.0% | $0.40 | — | *W EXP 09/22/202 | 671005114 |
| — | RELATIVITY ACQUISITION CORP | 100,000 | $3,010 | 0.0% | $0.03 | — | *W EXP 12/15/202 | 75944B114 |
| — | COLISEUM ACQUISITION CORP | 28,333 | $2,026 | 0.0% | $0.81 | — | *W EXP 08/22/202 | G2263T107 |
| TCBWF | TC BIOPHARM HOLDINGS PLC | 18,823 | $1,684 | 0.0% | $0.49 | — | *W EXP 02/08/202 | 87807D111 |
| — | COLOMBIER ACQUISITION CORP | 16,666 | $1,433 | 0.0% | $0.54 | — | *W EXP 99/99/999 | 19533H116 |